BioCentury
ARTICLE | Clinical News

ThPTH: Phase I

December 22, 2003 8:00 AM UTC

TH started a controlled, U.K. Phase I trial in 10-30 healthy volunteers comparing ThPTH to Forteo teriparatide, a recombinant form of PTH 1-34 marketed by Eli Lilly and Co. (LLY, Indianapolis, Ind....